BNT162b2 Still Effective, but Less So, Against Omicron
Vaccine effectiveness 70 percent compared with 93 percent against hospitalization for COVID-19 during delta predominance
Israel Will Give Fourth COVID-19 Shot to People Older Than 60, Health Workers
About 60 percent of Israel's 9.4 million people are fully vaccinated with either a recent second dose or booster dose
Negative COVID-19 Test May Be Required After Isolation Among Asymptomatic
CDC is considering adding extra safeguard after getting some 'pushback' on its Dec. 27 guidance that shortened isolation times
Machine Learning IDs Predictors of Treatment Response in RA
Machine learning integrating clinical and genomic data can predict methotrexate treatment response in early rheumatoid arthritis
Frail Patients With Nonvalvular A-Fib Less Likely to Receive Anticoagulants
Frail patients with nonvalvular atrial fibrillation also less likely to receive a direct oral anticoagulant versus warfarin
FDA Approves Pfizer Booster Shots for Children Ages 12 to 15
Agency also reduced the period people must wait between their second dose and booster shot from six to five months
AAN Updates Guideline for Treatment of Painful Diabetic Neuropathy
When patients do not experience meaningful improvement with initial therapeutic class, medication from different class should be offered
Most COVID-19-Related EUAs Not Supported by High-Quality Evidence
Most EUAs were for diagnostic products; most supported by comparisons with previously authorized assays, analytical in vitro studies
Rivaroxaban Improves Clinical Outcomes After COVID-19 Hospitalization
Risk for thrombotic events reduced after 35 days of rivaroxaban compared with no extended thromboprophylaxis
Dolutegravir-Based ART Superior for Children, Teens With HIV
Rate of serious adverse events similar for participants receiving dolutegravir, standard care as first-, second-line treatment for HIV-1 infection
